DrugPatentWatch Database Preview
Drugs in MeSH Category Neuroprotective Agents
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 089207-001 | Apr 25, 1988 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Lupin Ltd | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 209097-002 | Feb 22, 2019 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Jubilant Cadista | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 040189-002 | Oct 31, 1997 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Breckenridge | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 209063-002 | Nov 26, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Alvogen | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 204403-003 | Aug 31, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Alvogen | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 204403-002 | Sep 3, 2015 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
